Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;69(6):1482-1486.
doi: 10.4103/ijo.IJO_2428_20.

A study analyzing the health-related quality of life of retinoblastoma survivors in India

Himani Dhingra  1 , Deepanjali Arya  2 , Ankit Taluja  3 , Sima Das  2 , Amita Mahajan  1
Affiliations

A study analyzing the health-related quality of life of retinoblastoma survivors in India

Himani Dhingra et al. Indian J Ophthalmol. 2021 Jun.

Abstract

Purpose: : Retinoblastoma (RB) is the commonest intraocular tumor in children. Despite high cure rates, data on health-related quality of life (HRQoL) of RB survivors are limited. This study aimed to analyze parent's perspective and self-report of HRQoL of RB survivors, using healthy siblings as controls. It also evaluated the impact of socio-economic status (SES), gender, disease laterality, treatment modality, duration since diagnosis, and visual outcomes, on HRQoL.

Methods: Ninety-two RB survivors were enrolled in this observational, cross-sectional questionnaire-based study conducted at a tertiary care center. QoL was analyzed in four dimensions: physical, emotional, social, and school, using both self-report (for children >6 years) and parent proxy report (for children 2-18 years) using Pediatric Quality of Life Inventory™ (PedsQLTM) 4.0 Generic Core Scale. Seventy-seven healthy siblings served as controls.

Results: The mean age of both cohorts was 5.7 years. Thirty-six (39%) patients had bilateral RB. Of the 92 survivors, 43 (47%) had undergone enucleation. The HRQoL of RB survivors was significantly lower compared to sibling controls (P < 0.01) in all four domains, the physical domain being most affected followed by social domain. Parents reported an inferior QoL than patient's self-report. Vision <6/18 in the best eye and enucleation had a negative impact on HRQoL whilst gender, disease laterality, duration since diagnosis and SES had no impact.

Conclusion: : QoL assessment is often neglected but an important aspect of survivorship. Results of our study will help in formulating awareness of the domains affected and allow timely advocacy of initiatives for addressing each issue individually. Remedial measures aimed at optimizing QoL should be incorporated as part of their rehabilitation.

Keywords: Health-related quality of life; pediatric quality of life; retinoblastoma; survivors.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
Heath-related quality of life (HRQoL) scores of various dimensions in RB survivors and controls
See this image and copyright information in PMC

References

    1. Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 2009;93:21–3. - PubMed
    1. Seregard S, Lundell G, Svedberg H, Kivelä T. Incidence of retinoblastoma from 1958 to 1998 in Northern Europe: Advantages of birth cohort analysis. Ophthalmology. 2004;111:1228–32. - PubMed
    1. Kivela T. The epidemiological challenge of the most frequent eye cancer: Retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129–31. - PubMed
    1. Van Dijk J, Huisman J, Moll AC, Schouten-van Meeteren AY, Bezemer PD, Ringens PJ, et al. Health-related quality of life of child and adolescent of retinoblastoma survivors in the Netherlands. Health Qual Life Outcomes. 2007;5:65. - PMC - PubMed
    1. Alessi D, Dama E, Barr R, Mosso ML, Maule M, Magnani C, et al. Health related quality of life of long-term childhood cancer survivors: A population-based study from the Childhood Cancer Registry of Piedmont, Italy. Eur J Cancer. 2007;43:2545–52. - PubMed